{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T12:02:03Z","timestamp":1789646523057,"version":"4.0.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["OT2HL156812"],"award-info":[{"award-number":["OT2HL156812"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Qual Life Res"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s11136-026-04340-7","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T16:24:25Z","timestamp":1784823865000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Item comprehension and content coverage of patient-reported outcome measures for long COVID: a qualitative study"],"prefix":"10.1007","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8996-7757","authenticated-orcid":false,"given":"Christina K.","family":"Zigler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charis","family":"Yousefian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rikki","family":"Mangrum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maliyah","family":"Faulstich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean M.","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Maughan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Cerda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucinda","family":"Bateman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyndya A.","family":"Shibao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry","family":"Make","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard A.","family":"Jason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin P.","family":"Weinfurt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanecia O.","family":"Zimmerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"key":"4340_CR1","unstructured":"National Center for Health Statistics. (2025). U.S. Census Bureau HPS, 2022\u20132024. Long COVID. Generated interactively: July 1, 2025 from https:\/\/www.cdc.gov\/nchs\/covid19\/pulse\/long-covid.htm."},{"issue":"4","key":"4340_CR2","doi-asserted-by":"publisher","first-page":"e102","DOI":"10.1016\/S1473-3099(21)00703-9","volume":"22","author":"JB Soriano","year":"2022","unstructured":"Soriano, J. B., Murthy, S., Marshall, J. C., Relan, P., & Diaz, J. V. (2022). A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infectious Diseases, 22(4), e102\u2013e107. https:\/\/doi.org\/10.1016\/S1473-3099(21)00703-9","journal-title":"Lancet Infectious Diseases"},{"issue":"1","key":"4340_CR3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1001\/jama.2024.11370","volume":"332","author":"Z Fang","year":"2024","unstructured":"Fang, Z., Ahrnsbrak, R., & Rekito, A. (2024). Evidence mounts that about 7% of US adults have had long COVID. JAMA, 332(1), 5\u20136. https:\/\/doi.org\/10.1001\/jama.2024.11370","journal-title":"JAMA"},{"issue":"3","key":"4340_CR4","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41579-022-00846-2","volume":"21","author":"HE Davis","year":"2023","unstructured":"Davis, H. E., McCorkell, L., Vogel, J. M., & Topol, E. J. (2023). Long COVID: Major findings, mechanisms and recommendations. Nature Reviews Microbiology, 21(3), 133\u2013146. https:\/\/doi.org\/10.1038\/s41579-022-00846-2","journal-title":"Nature Reviews Microbiology"},{"key":"4340_CR5","doi-asserted-by":"publisher","first-page":"1157651","DOI":"10.3389\/fmolb.2023.1157651","volume":"10","author":"G Kenny","year":"2023","unstructured":"Kenny, G., Townsend, L., Savinelli, S., & Mallon, P. W. G. (2023). Long COVID: Clinical characteristics, proposed pathogenesis and potential therapeutic targets. Frontiers in Molecular Biosciences, 10, 1157651. https:\/\/doi.org\/10.3389\/fmolb.2023.1157651","journal-title":"Frontiers in Molecular Biosciences"},{"key":"4340_CR6","unstructured":"RECOVER. RECOVER clinical trials. https:\/\/trials.recovercovid.org\/."},{"issue":"32","key":"4340_CR7","doi-asserted-by":"publisher","first-page":"866","DOI":"10.15585\/mmwr.mm7232a3","volume":"72","author":"ND Ford","year":"2022","unstructured":"Ford, N. D., Slaughter, D., Edwards, D., et al. (2022). Long COVID and significant activity limitation among adults, by age - United States, June 1\u201313, 2022, to June 7\u201319, 2023. MMWR Morbidity and Mortality Weekly Report, 72(32), 866\u2013870. https:\/\/doi.org\/10.15585\/mmwr.mm7232a3","journal-title":"MMWR Morbidity and Mortality Weekly Report"},{"issue":"8","key":"4340_CR8","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1038\/s41591-024-03173-6","volume":"30","author":"Z Al-Aly","year":"2024","unstructured":"Al-Aly, Z., Davis, H., McCorkell, L., et al. (2024). Long COVID science, research and policy. Nature Medicine, 30(8), 2148\u20132164. https:\/\/doi.org\/10.1038\/s41591-024-03173-6","journal-title":"Nature Medicine"},{"key":"4340_CR9","unstructured":"Food and Drug Administration. (2025). Patient-focused drug development: Selecting, developing, or modifying fit-for-purpose clinical outcome assessments. Guidance for Industry, Food and Drug Administration Staff, and Other Stakeholders. https:\/\/www.fda.gov\/media\/159500\/download."},{"key":"4340_CR10","unstructured":"Food and Drug Administration. (2009). Guidance for industry: Patient-reported outcome measures: Use in medical product development to support labeling claims. https:\/\/www.fda.gov\/media\/77832\/download."},{"key":"4340_CR11","unstructured":"Food and Drug Administration. (2023). Patient-focused drug development: incorporating clinical outcome assessments into endpoints for regulatory decision-making: Guidance for industry, food and drug administration staff, and other stakeholders (draft guidance). https:\/\/www.fda.gov\/media\/166830\/download ."},{"key":"4340_CR12","unstructured":"US Centers for Disease Control and Prevention. (2025). Clinical overview of long COVID. Accessed 1 July 2025. https:\/\/www.cdc.gov\/covid\/hcp\/clinical-overview\/index.html"},{"issue":"9","key":"4340_CR13","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.7326\/m24-0737","volume":"177","author":"KM Erlandson","year":"2024","unstructured":"Erlandson, K. M., Geng, L. N., Selvaggi, C. A., et al. (2024). Differentiation of prior SARS-CoV-2 infection and postacute sequelae by standard clinical laboratory measurements in the RECOVER cohort. Annals of Internal Medicine, 177(9), 1209\u20131221. https:\/\/doi.org\/10.7326\/m24-0737","journal-title":"Annals of Internal Medicine"},{"issue":"5","key":"4340_CR14","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/s41590-025-02135-5","volume":"26","author":"Y Gao","year":"2025","unstructured":"Gao, Y., Cai, C., Adamo, S., et al. (2025). Identification of soluble biomarkers that associate with distinct manifestations of long COVID. Nature Immunology, 26(5), 692\u2013705. https:\/\/doi.org\/10.1038\/s41590-025-02135-5","journal-title":"Nature Immunology"},{"key":"4340_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics8030066","author":"J Cotler","year":"2018","unstructured":"Cotler, J., Holtzman, C., Dudun, C., & Jason, L. A. (2018). A brief questionnaire to assess post-exertional malaise. Diagnostics. https:\/\/doi.org\/10.3390\/diagnostics8030066","journal-title":"Diagnostics"},{"key":"4340_CR16","doi-asserted-by":"publisher","unstructured":"Jason, L.A., Evans, M., Porter, N., et al. (2010). The development of a revised Canadian myalgic encephalomyelitis chronic fatigue syndrome case definition. Am J Biochem Biotechnol. 6(2), 120\u2013135. https:\/\/doi.org\/10.3844\/ajbbsp.2010.120.135","DOI":"10.3844\/ajbbsp.2010.120.135"},{"issue":"3","key":"4340_CR17","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1097\/wad.0000000000000450","volume":"35","author":"ST Farias","year":"2021","unstructured":"Farias, S. T., Weakley, A., Harvey, D., Chandler, J., Huss, O., & Mungas, D. (2021). The measurement of everyday cognition (ECog): Revisions and updates. Alzheimer Disease and Associated Disorders, 35(3), 258\u2013264. https:\/\/doi.org\/10.1097\/wad.0000000000000450","journal-title":"Alzheimer Disease and Associated Disorders"},{"issue":"6","key":"4340_CR18","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1111\/jgs.14835","volume":"65","author":"ST Farias","year":"2017","unstructured":"Farias, S. T., Lau, K., Harvey, D., Denny, K. G., Barba, C., & Mefford, A. N. (2017). Early functional limitations in cognitively normal older adults predict diagnostic conversion to mild cognitive impairment. Journal of the American Geriatrics Society, 65(6), 1152\u20131158. https:\/\/doi.org\/10.1111\/jgs.14835","journal-title":"Journal of the American Geriatrics Society"},{"issue":"12","key":"4340_CR19","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1016\/j.mayocp.2012.10.013","volume":"87","author":"DM Sletten","year":"2012","unstructured":"Sletten, D. M., Suarez, G. A., Low, P. A., Mandrekar, J., & Singer, W. (2012). COMPASS 31: A refined and abbreviated Composite Autonomic Symptom Score. Mayo Clinic Proceedings, 87(12), 1196\u20131201. https:\/\/doi.org\/10.1016\/j.mayocp.2012.10.013","journal-title":"Mayo Clinic Proceedings"},{"issue":"2","key":"4340_CR20","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s10286-011-0146-2","volume":"22","author":"H Kaufmann","year":"2012","unstructured":"Kaufmann, H., Malamut, R., Norcliffe-Kaufmann, L., Rosa, K., & Freeman, R. (2012). The orthostatic hypotension questionnaire (OHQ): Validation of a novel symptom assessment scale. Clinical Autonomic Research, 22(2), 79\u201390. https:\/\/doi.org\/10.1007\/s10286-011-0146-2","journal-title":"Clinical Autonomic Research"},{"issue":"8","key":"4340_CR21","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.jval.2011.06.013","volume":"14","author":"DL Patrick","year":"2011","unstructured":"Patrick, D. L., Burke, L. B., Gwaltney, C. J., et al. (2011). Content validity\u2014establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: Part 2\u2014assessing respondent understanding. Value in Health, 14(8), 978\u2013988. https:\/\/doi.org\/10.1016\/j.jval.2011.06.013","journal-title":"Value in Health"},{"key":"4340_CR22","doi-asserted-by":"publisher","first-page":"330","DOI":"10.3389\/fped.2018.00330","volume":"6","author":"LA Jason","year":"2018","unstructured":"Jason, L. A., & Sunnquist, M. (2018). The development of the DePaul symptom questionnaire: Original, expanded, brief, and pediatric versions. Frontiers in Pediatrics, 6, 330. https:\/\/doi.org\/10.3389\/fped.2018.00330","journal-title":"Frontiers in Pediatrics"},{"issue":"4","key":"4340_CR23","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1037\/0894-4105.22.4.531","volume":"22","author":"ST Farias","year":"2008","unstructured":"Farias, S. T., Mungas, D., Reed, B. R., et al. (2008). The measurement of everyday cognition (ECog): Scale development and psychometric properties. Neuropsychology, 22(4), 531\u2013544. https:\/\/doi.org\/10.1037\/0894-4105.22.4.531","journal-title":"Neuropsychology"},{"issue":"3","key":"4340_CR24","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1212\/wnl.52.3.523","volume":"52","author":"GA Suarez","year":"1999","unstructured":"Suarez, G. A., Opfer-Gehrking, T. L., Offord, K. P., Atkinson, E. J., O\u2019Brien, P. C., & Low, P. A. (1999). The autonomic symptom profile: A new instrument to assess autonomic symptoms. Neurology, 52(3), 523\u2013528. https:\/\/doi.org\/10.1212\/wnl.52.3.523","journal-title":"Neurology"},{"issue":"5","key":"4340_CR25","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1046\/j.1360-0443.1999.9457159.x","volume":"94","author":"J Bisson","year":"1999","unstructured":"Bisson, J., Nadeau, L., & Demers, A. (1999). The validity of the CAGE scale to screen for heavy drinking and drinking problems in a general population survey. Addiction, 94(5), 715\u2013722. https:\/\/doi.org\/10.1046\/j.1360-0443.1999.9457159.x","journal-title":"Addiction"},{"issue":"1","key":"4340_CR26","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1177\/1525822X05279903","volume":"18","author":"G Guest","year":"2006","unstructured":"Guest, G., Bunce, A., & Johnson, L. (2006). How many interviews are enough? An experiment with data saturation and variability. Field Methods, 18(1), 59\u201382.","journal-title":"Field Methods"},{"issue":"8","key":"4340_CR27","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1111\/j.1524-4733.2009.00603.x","volume":"12","author":"M Rothman","year":"2009","unstructured":"Rothman, M., Burke, L., Erickson, P., Leidy, N. K., Patrick, D. L., & Petrie, C. D. (2009). Use of existing patient-reported outcome (PRO) instruments and their modification: The ISPOR good research practices for evaluating and documenting content validity for the use of existing instruments and their modification PRO task force report. Value in Health, 12(8), 1075\u20131083. https:\/\/doi.org\/10.1111\/j.1524-4733.2009.00603.x","journal-title":"Value in Health"},{"issue":"8","key":"4340_CR28","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1007\/s00406-023-01661-3","volume":"274","author":"PA Reuken","year":"2024","unstructured":"Reuken, P. A., Besteher, B., Finke, K., et al. (2024). Longterm course of neuropsychological symptoms and ME\/CFS after SARS-CoV-2-infection: A prospective registry study. European Archives of Psychiatry and Clinical Neuroscience, 274(8), 1903\u20131910. https:\/\/doi.org\/10.1007\/s00406-023-01661-3","journal-title":"European Archives of Psychiatry and Clinical Neuroscience"},{"issue":"6","key":"4340_CR29","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.3390\/jcm13061712","volume":"13","author":"K Kaczmarczyk","year":"2024","unstructured":"Kaczmarczyk, K., Matharu, Y., Bobowik, P., Gajewski, J., Maciejewska-Skrendo, A., & Kulig, K. (2024). Resistance exercise program is feasible and effective in improving functional strength in post-COVID survivors. Journal of Clinical Medicine, 13(6), 1712.","journal-title":"Journal of Clinical Medicine"},{"issue":"4","key":"4340_CR30","doi-asserted-by":"publisher","first-page":"e244386","DOI":"10.1001\/jamanetworkopen.2024.4386","volume":"7","author":"A Tryfonos","year":"2024","unstructured":"Tryfonos, A., Pourhamidi, K., J\u00f6rn\u00e5ker, G., et al. (2024). Functional limitations and exercise intolerance in patients with post-COVID condition: A randomized crossover clinical trial. JAMA Network Open, 7(4), e244386\u2013e244386. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.4386","journal-title":"JAMA Network Open"},{"key":"4340_CR31","unstructured":"Food and Drug Administration. (2024). Assessing COVID-19-related symptoms in outpatient adult and adolescent subjects in clinical trials of drugs and biological products for COVID-19 prevention and treatment: Guidance for industry. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/assessing-covid-19-related-symptoms-outpatient-adult-and-adolescent-subjects-clinical-trials-drugs"},{"issue":"9","key":"4340_CR32","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1056\/NEJMe2400189","volume":"390","author":"Z Al-Aly","year":"2024","unstructured":"Al-Aly, Z., & Rosen, C. J. (2024). Long COVID and impaired cognition\u2014More evidence and more work to do. New England Journal of Medicine, 390(9), 858\u2013860. https:\/\/doi.org\/10.1056\/NEJMe2400189","journal-title":"New England Journal of Medicine"},{"issue":"28","key":"4340_CR33","doi-asserted-by":"publisher","first-page":"e2426874122","DOI":"10.1073\/pnas.2426874122","volume":"122","author":"M Eckey","year":"2025","unstructured":"Eckey, M., Li, P., Morrison, B., Bergquist, J., Davis, R. W., & Xiao, W. (2025). Patient-reported treatment outcomes in ME\/CFS and long COVID. Proceedings of the National Academy of Sciences of the United States of America, 122(28), e2426874122. https:\/\/doi.org\/10.1073\/pnas.2426874122","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"4340_CR34","doi-asserted-by":"publisher","first-page":"e000284","DOI":"10.1136\/bmjmed-2022-000284","volume":"1","author":"JJ Kirkham","year":"2022","unstructured":"Kirkham, J. J., & Williamson, P. (2022). Core outcome sets in medical research. BMJ Medicine, 1(1), e000284. https:\/\/doi.org\/10.1136\/bmjmed-2022-000284","journal-title":"BMJ Medicine"},{"key":"4340_CR35","doi-asserted-by":"publisher","DOI":"10.1080\/23311908.2015.1079945","author":"M Evans","year":"2015","unstructured":"Evans, M., & Jason, L. A. (2015). The impact of symptom stability on time frame and recall reliability in CFS. Cogent Psychology. https:\/\/doi.org\/10.1080\/23311908.2015.1079945","journal-title":"Cogent Psychology"},{"issue":"3","key":"4340_CR36","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1177\/0163278713497014","volume":"38","author":"M Evans","year":"2015","unstructured":"Evans, M., & Jason, L. A. (2015). Effects of time frame on the recall reliability of CFS symptoms. Evaluation & the Health Professions, 38(3), 367\u2013381. https:\/\/doi.org\/10.1177\/0163278713497014","journal-title":"Evaluation & the Health Professions"},{"issue":"3","key":"4340_CR37","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1177\/1740774517698645","volume":"14","author":"TR Mendoza","year":"2017","unstructured":"Mendoza, T. R., Dueck, A. C., Bennett, A. V., et al. (2017). Evaluation of different recall periods for the US National Cancer Institute\u2019s PRO-CTCAE. Clinical Trials, 14(3), 255\u2013263. https:\/\/doi.org\/10.1177\/1740774517698645","journal-title":"Clinical Trials"},{"issue":"4","key":"4340_CR38","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.jval.2024.01.016","volume":"27","author":"C Arizmendi","year":"2024","unstructured":"Arizmendi, C., Wang, S., Kaplan, S., & Weinfurt, K. (2024). Evaluating recall periods for patient-reported outcome measures: A systematic review of quantitative methods. Value in Health, 27(4), 518\u2013526. https:\/\/doi.org\/10.1016\/j.jval.2024.01.016","journal-title":"Value in Health"},{"issue":"7","key":"4340_CR39","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1007\/s11136-018-1815-6","volume":"27","author":"M Hawkins","year":"2018","unstructured":"Hawkins, M., Elsworth, G. R., & Osborne, R. H. (2018). Application of validity theory and methodology to patient-reported outcome measures (PROMs): Building an argument for validity. Quality of Life Research, 27(7), 1695\u20131710. https:\/\/doi.org\/10.1007\/s11136-018-1815-6","journal-title":"Quality of Life Research"}],"container-title":["Quality of Life Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11136-026-04340-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11136-026-04340-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11136-026-04340-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T11:05:14Z","timestamp":1789643114000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11136-026-04340-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":39,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["4340"],"URL":"https:\/\/doi.org\/10.1007\/s11136-026-04340-7","relation":{},"ISSN":["0962-9343","1573-2649"],"issn-type":[{"value":"0962-9343","type":"print"},{"value":"1573-2649","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]},"assertion":[{"value":"19 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Charis Yousefian and Rikki Mangrum are employees of Vector Psychometric Group, LLC, which received funds from the Duke Clinical Research Institute (DCRI) to conduct the research detailed in the manuscript. No other disclosures were reported.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants provided informed consent and were compensated for their participation. The Duke University Health System institutional review board approved the study.","order":2,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"241"}}